# Leukemia & lymphoma/Leukemia and lymphoma

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/leukemia-and-lymphoma-leukemia-and-lymphoma/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1026-8022 |
| ISSNs | 1026-8022,1029-2403,1042-8194 |
| OpenAlex ID | https://openalex.org/S27064115 |
| Publisher | Taylor & Francis |

## Journal papers

- [Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure](https://scholariq.org/papers/delayed-intensive-care-unit-admission-is-associated-with-increased-mortality-in/)
- [Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients](https://scholariq.org/papers/rituximab-in-chronic-cold-agglutinin-disease-a-prospective-study-of-20-patients/)
- [Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database*](https://scholariq.org/papers/intravascular-large-b-cell-lymphoma-in-the-united-states-us-a-population-based/)
- [Pleural effusions in patients with acute leukemia and myelodysplastic syndrome](https://scholariq.org/papers/pleural-effusions-in-patients-with-acute-leukemia-and-myelodysplastic-syndrome/)
- [Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study](https://scholariq.org/papers/treatment-patterns-and-overall-survival-of-patients-with-double-class-and-triple/)
- [Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax](https://scholariq.org/papers/outcomes-of-antifungal-prophylaxis-for-newly-diagnosed-aml-patients-treated-with/)
- [Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study](https://scholariq.org/papers/different-outcomes-for-transplant-eligible-newly-diagnosed-multiple-myeloma/)
- [Evaluation of Telomerase mRNA (hTERT) in Childhood Acute Leukemia](https://scholariq.org/papers/evaluation-of-telomerase-mrna-htert-in-childhood-acute-leukemia/)
- [The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis](https://scholariq.org/papers/the-safety-of-bendamustine-in-patients-with-chronic-lymphocytic-leukemia-or-non/)
- [Randomized Comparison of Mobilization Kinetics of Circulating CD34+ Cells Between Biweekly CHOP and Dose-Escalated CHOP with the Prophylactic Use of Lenograstim (Glycosylated rHuG-CSF) in Aggressive Non-Hodgkin's Lymphoma](https://scholariq.org/papers/randomized-comparison-of-mobilization-kinetics-of-circulating-cd34-cells-between/)
- [Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group](https://scholariq.org/papers/primary-plasma-cell-leukemia-in-latin-america-demographic-clinical-and/)
- [Predictors and timing of venous thromboembolism and overall survival in lymphoma](https://scholariq.org/papers/predictors-and-timing-of-venous-thromboembolism-and-overall-survival-in-lymphoma/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.